The 56 rating InvestorsObserver gives to Supernus Pharmaceuticals Inc (SUPN) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 84 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, SUPN’s 56 overall rating means the stock scores better than 56 percent of all stocks.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Supernus Pharmaceuticals Inc Stock Today?
Supernus Pharmaceuticals Inc (SUPN) stock is up 1.28% while the S&P 500 is down -0.79% as of 2:11 PM on Wednesday, Mar 3. SUPN is up $0.32 from the previous closing price of $24.97 on volume of 453,396 shares. Over the past year the S&P 500 is higher by 27.84% while SUPN is up 38.73%. SUPN earned $2.41 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 10.49.
Click Here to get the full Stock Score Report on Supernus Pharmaceuticals Inc (SUPN) Stock.
